Production of interleukin (IL)-6 and IL-8 by a choriocarcinoma cell line, BeWo

Placenta

Volumn 21, Issue 4, 2000, Pages 354-360

  Fujisawa, K ^a   Nasu, K ^a   Arima, K ^a   Sugano, T ^a   Narahara, H ^a   Miyakawa, I ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; DEXAMETHASONE; FORSKOLIN; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CHORIOCARCINOMA; DOSE RESPONSE; PRIORITY JOURNAL;

EID: 0034044486     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1053/plac.1999.0494     Document Type: Article

References (31)

1. Abruzzo LV, Thornton AJ, Liebert M, Grossman HB, Evanoff H, Westwick J, Strieter RM, Kunkel SL. Cytokine-induced gene expression of interleukin-8 in human transitional cell carcinomas and renal cell carcinomas. Am J Pathol. 140:1992;365-373.
2. Bennett WA, Lagoo-Deenadayalan S, Brackin MN, Hale E, Cowan BD. Cytokine expression by models of human trophoblast as assessed by a semiquantitative reverse transcription-polymerase chain reaction technique. Am J Reprod Immunol. 36:1996;285-294.
3. Cross M, Deter TM. Growth factors in development, transformation, and tumorigenesis. Cell. 64:1991;271-280.
4. Frolik CA, Dart LL, Meyers CA, Smith DM, Sporn MB. Purification and initial characterization of a type beta transforming growth factor from human placenta. Proc Natl Acad Sci USA. 80:1983;3676-3680.
5. Haynes MK, Jackson LG, Tuan RS, Shepley KJ, Smith JB. Cytokine production in first trimester chorionic villi: detection of mRNAs and protein products in situ. Cell Immunol. 151:1993;300-308.
6. Hirano T, Taga T, Yasukawa K, Nakajima K, Nakano N, Takatsuki F, Shimizu M, Murashima A, Tsunasawa S, Sakiyama F, Kishimoto T. Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production. Proc Natl Acad Sci USA. 84:1987;228-231.
7. Knöfler M, Kiss H, Mösl B, Egarter C, Husslein P. Interleukin-1 stimulates tumor necrosis factor-α (TNF-α) release from cytotrophoblastic BeWo cells independently of induction of the TNF-α mRNA. FEBS Lett. 405:1997;213-218.
8. Kong B, Isozaki T, Sasaki S. IL-6 antisense-mediated growth inhibition of a choriocarcinoma cell line: an intracellular autocrine growth mechanism. Gynecol Oncol. 63:1996;78-84.
9. Lang GA, Burgess AW. Autocrine growth factors and tumorigenic transformation. Immunol Today. 11:1990;244-249.
10. Matsuzaki N, Li Y, Masuhiro K, Jo T, Shimoya K, Taniguchi T, Saji F, Tanizawa O. Trophoblast-derived transforming growth factor-β1 suppresses cytokine-induced, but not gonadotropin releasing hormone-induced release of human chorionic gonadotropin by normal human trophoblasts. J Clin Endocrinol Metab. 74:1992;211-216.
11. Miki S, Iwano M, Miki Y, Yamamoto M, Tang B, Yokokawa K, Sonoda T, Hirano T, Kishimoto T. Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas. FEBS Lett. 250:1989;607-610.
12. Morrish DW, Bhardwaj D, Paras MT. Transforming growth factor β1 inhibits placental differentiation and human chorionic gonadotropin and human placental lactogen secretion. Endocrinology. 129:1991;22-26.
13. Motro B, Itin A, Sachs L, Keshet E. Pattern of interleukin-6 gene expression in vivo suggests a role for this cytokine in angiogenesis. Proc Natl Acad Sci USA. 87:1990;3092-3096.
14. Nasu K, Matsui N, Narahara H, Tanaka Y, Takai N, Miyakawa I, Higuchi Y. MaMi, a human endometrial stromal sarcoma cell line that constitutively produces interleukin (IL)-6, IL-8, and monocyte chemoattractant protein-1. Arch Pathol Lab Med. 122:1998;836-841.
15. Nasu K, Narahara H, Matsui N, Kawano Y, Tanaka Y, Miyakawa I. Platelet-activating factor stimulates cytokine production by human endometrial stromal cells. Mol Hum Reprod. 5:1999;548-553.
16. Opdenakker G, Van Damme J. Chemotactic factors, passive invasion and metastasis of cancer cells. Immunol Today. 13:1992;463-464.
17. Pattillo RA, Gey GO. The establishment of a cell line of human hormone-synthesizing trophoblastic cells in vitro. Cancer Res. 28:1969;1231-1236.
18. Rosen T, Krikun G, Ma Y, Wang E-Y, Lockwood CJ, Guller S. Chronic antagonism of nuclear factor-κB activity in cytotrophoblasts by dexamethasone: a potential mechanism for antiinflammatory action of glucocorticoids in human placenta. J Clin Endocrinol Metab. 83:1998;3647-3652.
19. Sakamoto K, Masuda T, Mita S, Ishiko T, Nakashima Y, Arakawa H, Egami H, Harada S, Matsushima K, Ogawa M. Interleukin-8is constitutively and commonly produced by various human carcinoma cell lines. Int J Clin Lab Res. 22:1992;216-219.
20. Scambia G, Testa U, Panici PB, Martucci R, Foti E, Petrini M, Amoroso M, Masciullo V, Peschle C, Mancuso S. Interleukin-6 serum levels in patients with gynecological tumors. Int J Cancer. 57:1994;318-323.
21. Shaarawy M, Darwish NA. Serum cytokines in gestational trophoblastic diseases. Acta Oncol. 34:1995;177-182.
22. Silverberg SG, Kurman RJ. Tumors of the uterine corpus and gestational trophoblastic disease. Atlas of Tumor Pathology, 3rd ed. 1992;Armed Forces Institute of Pathology, Washington.
23. Simpson ER, McDonald PC. Endocrine physiology of the placenta. Ann Rev Physiol. 43:1981;163-188.
24. Stephanou A, Handwerger S. Interleukin-6 stimulates placental lactogen expression by human trophoblast cells. Endocrinology. 135:1994;719-723.
25. Takenawa J, Kaneko Y, Fukumoto M, Fukatsu A, Hirano T, Fukuyama H, Nakayama H, Fujita J, Yoshida O. Enhanced expression of interleukin-6 in primary human renal cell carcinomas. J Natl Cancer Inst. 83:1991;1668-1672.
26. Taniguchi T, Matsuzaki N, Jo T, Saji F, Taga T, Hirano T, Kishimoto T, Tanizawa O. Interleukin-1 (IL-1)-induced IL-6-receptor-mediated release of human chorionic gonadotropin by choriocarcinoma cell lines (Jar and HCCM-5) activates adenosine 3′,5′-monophosphate-independent signal transduction pathway. J Clin Endocrinol Metab. 74:1992;1389-1395.
27. Tartour E, Dorval T, Mosseri V, Deneux L, Mathiot C, Brailly H, Montero F, Joyeux I, Pouillart P, Fridman WH. Serum interleukin-6 and c-reactive protein levels correlate with resistance to IL-2 therapy and poor survival in melanoma patients. Br J Cancer. 69:1994;911-913.
28. Van Meir E, Savamura Y, Diserens A-C, Hamou MF, De Tribolot N. Human glioblastoma cells release interleukin 6 in vivo and in vitro. Cancer Res. 50:1990;6683-6688.
29. Watson JM, Berek JS, Martínez-Maza O. Growth inhibition of ovarian cancer cells induced by antisense IL-6 oligonucleotides. Gynecol Oncol. 49:1993;8-15.
30. Watson JM, Sensintaffar JL, Berek JS, Martínez-Maza O. Constitutive production of interleukin-6 by ovarian cancer cell lines and by ovarian tumor cultures. Cancer Res. 50:1990;6959-6965.
31. Yoneda J, Kuniyasu H, Crispens MA, Price JE, Bucana CD, Fidler IJ. Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice. J Natl Cancer Inst. 90:1998;447-454.